Manufacturing Expansion In Malaysia And Europe Will Create Resilient Diversification

Key Takeaways

• Geographic expansion and operational efficiencies strengthen inTEST's ability to serve customers, manage supply chain risks, and drive sustainable margin and revenue growth.
  
• Diversification into multiple end-markets and innovative product development enhances revenue stability, margin expansion, and positions the company for profitable scaling as industry capital spending rises.
  
• Persistent weakness in core semiconductor and automotive markets, coupled with limited diversification progress and high execution risk, threatens sustained revenue growth and long-term market position.

Catalysts

Provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets in the United States and internationally.

• Recent and planned expansion of manufacturing in Malaysia and Europe enables inTEST to better serve regional customers, capture cost efficiencies, and hedge against tariffs and supply chain disruptions-this is expected to enhance operational margins and drive medium-term revenue growth as semiconductor and electronics manufacturing regionalizes.
  
• A record-high opportunity pipeline and growing customer interest in inTEST's innovative new products positions the company to capitalize on anticipated capital spending in AI, automotive electrification, and industrial automation once market uncertainties subside, which should accelerate top-line revenue expansion.
  
• Diversification beyond semiconductors into defense, automotive/EV, life sciences, and safety/security markets is yielding increasing orders and reduced cyclicality, enhancing revenue resilience and opening new, higher-margin growth vectors.
  
• Ongoing introduction of differentiated thermal and test solutions continues to drive margin improvement (e.g., Q2 gross margin improvement of 110bps sequentially); as more customers require advanced, AI-optimized, and precision testing, inTEST is positioned to achieve higher selling prices and margin expansion.
  
• Operating cost control, facility consolidation, and debt reduction strengthen balance sheet flexibility and position the company to scale profitably as industry capital expenditures recover, supporting long-term earnings and net margin improvement.

inTEST Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming inTEST's revenue will grow by 3.6% annually over the next 3 years.
• Analysts are not forecasting that inTEST will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate inTEST's profit margin will increase from -0.7% to the average US Semiconductor industry of 14.4% in 3 years.
• If inTEST's profit margin were to converge on the industry average, you could expect earnings to reach $19.5 million (and earnings per share of $1.62) by about August 2028, up from $-833.0 thousand today.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 8.4x on those 2028 earnings, up from -105.3x today. This future PE is lower than the current PE for the US Semiconductor industry at 30.0x.
• Analysts expect the number of shares outstanding to decline by 0.31% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 11.12%, as per the Simply Wall St company report.

inTEST Future Earnings Per Share Growth

Risks

• Ongoing global economic and tariff uncertainties continue to drive customer hesitancy with larger capital projects, contributing to limited visibility on future orders and a persistent weakness in the critical semiconductor (semi) segment, which increases risk for future revenue growth and backlog stability.
  
• The company reports sequential improvements, but overall year-over-year revenue and backlog are down, primarily due to declines in core end-markets such as automotive/EV and semiconductor, highlighting its exposure to cyclical downturns and the risk of uneven recovery affecting both top-line revenue and earnings.
  
• Intense expense control, including headcount reductions and austerity measures, has supported margin stabilization but may not be sustainable long-term; a significant portion of these cost savings are temporary and would reverse as the business scales up, potentially creating margin compression as operating expenses rise with revenue recovery.
  
• The ramp-up of the new Malaysia facility is intended to support geographic expansion and cost efficiencies, but execution risk remains around the pace of ramping production and achieving the targeted $10–15 million revenue contribution, which could impact both revenue growth forecasts and gross margins if delays or underutilization occur.
  
• The company's diversification efforts have shown some promise in defense/aero and life sciences, but these markets may not fully offset structural weakness in the semiconductor and automotive sectors; failure to achieve sufficient diversification or adapt to rapidly evolving industry needs (e.g., advanced semiconductor packaging, vertically integrated customers) could result in stagnant or declining revenue and long-term loss of market share.

Valuation

• The analysts have a consensus price target of $10.0 for inTEST based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $12.0, and the most bearish reporting a price target of just $8.0.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $135.3 million, earnings will come to $19.5 million, and it would be trading on a PE ratio of 8.4x, assuming you use a discount rate of 11.1%.
• Given the current share price of $7.17, the analyst price target of $10.0 is 28.3% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.